Nephron Sterile Compounding Center LLC recalls Calcium Gluconate Injection, USP 10%, 0.465 mEq Ca++/mL, 1 g/10 mL (100 mg/mL), 10 mL Pre-Filled Syringe, 5 x 10…
Lack of Assurance of Sterility
Read the official notice →- Date
- 2022-06-08
- Country
- United States
- Brand
- Nephron Sterile Compounding Center
- Product
- Calcium Gluconate Injection, USP 10%, 0.465 mEq Ca++/mL, 1 g/10 mL (100 mg/mL), 10 mL Pre-Filled Syringe, 5 x 10 Pre-filled Syringes, 6 x…
- Classification
- Class II
- Units
- Nationwide in the USA
- Category
- Drugs & medical
- Source
- FDA · Drug
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More Nephron Sterile Compounding Center recalls
- 2025-03-19
USNephron Sterile Compounding Center LLC recalls Sodium Chloride Injection 9%, USP, 500 mL, Single-Dose IV Bottle, Rx Only, nephron, 503B outsourcing facility, West…
Lack of Assurance of Sterility: There is a potential for leakage at the IV bottle port.
- 2023-03-08
- US
- 2023-01-18
- US
- 2022-11-23
- US
Nephron Sterile Compounding Center LLC recalls PF-Neostigmine Methylsulfate Injection, USP 3 mg/3 mL (1 mg/mL) vial, Rx Only, Nephron 503B Outsourcing Facility 4500…
CGMP Deviations: Potential for cross contamination due to product carry over.
- 2022-08-24
- US
Nephron Sterile Compounding Center LLC recalls PF-Neostigmine Methylsulfate Injection, USP, 3 mg/3 mL (1 mg/mL), One 3 mL Unit-Dose Vial, packaged in 30 x 3 mL Sterile…
CGMP Deviations: Potential for cross-contamination due to product carryover during manufacturing.
- 2022-07-27
- US
Other drugs & medical recalls in the United States
- 2022-06-08
- US
Strides Pharma Inc. recalls Losartan Potassium Tablets, USP, 50 mg, Rx Only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No., 101, 102, 107 & 108,…
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
- US
Direct Rx recalls Losartan Pot./HCTZ 100/12.5 mg Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Mfg For: Lupin Pharmaceuticals, Inc.…
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
- US
Vi-Jon, LLC recalls Equate Tartar Control Plus (Eucalyptol 0.092%, Menthol 0.042%, Methyl salicylate 0.060%, Thymol 0.064%) Antiseptic Mouthrise Plus,…
Superpotent Drug: product complaint for milky blue appearance and consistency, further investigation by the firm found the recalled lots out of specification for the four active ingredients.
- 2022-06-02
- US
Asweets Recalls Wood Baby Activity Push Walkers Due to Strangulation Hazard
Rubber rings on the rear wheels can separate from the wheels and detach from the Activity Walkers, posing a strangulation hazard to young children.
- 2022-06-01
- US
MEDLINE INDUSTRIES, LP - Northfield recalls ABX Pentra Calcium AS CP, Reagent 90 mL, REF A11A01954
Product was shipped from a Medline warehouse to a customer at room temperature instead of refrigerated (ice). If affected product is used, the results from this impacted Calcium reagent will not be provided due to…
- US
ProgenaCare recalls progenamatrix Human Keratin Matrix, sterile, Rx, with the following model numbers: (1) PM2012, 12 x 2 cm; (2) PM3002, 2 x 2 cm; (3)…
Inner pouch seal may be inadequate resulting in lack of sterility.
FDA · DeviceProgenaCareUS Nationwide distribution in the states of AL, GA, FL, TN, and TX. There was…Official notice →